The Association between IL6-174 G/C Gene Polymorphism and Obesity: A Systematic Review and Meta-analysis

Document Type : Review Article/ Systematic Review Article/ Meta Analysis

Authors

1 Master of Science, Department of Physical Education and Sport Sciences, Faculty of Literature and Humanities, Lorestan University, Khoramabad, Iran

2 Associate Professor, Department of Physical Education and Sport Sciences, Faculty of Literature and Humanities, Lorestan University, Khoramabad, Iran

3 Assistant Professor, Department of Physical Education and Sport Sciences, Faculty of Literature and Humanities, Lorestan University, Khoramabad, Iran

Abstract

Background: The interaction between genetic and environmental factors has resulted in growing prevalence of obesity around the world. IL6-174 G/Cgene polymorphism is widely studied as the involved factor in developing obesity.

Objectives: The aim of the present study is to evaluate the relationship between Interleukin 6-174 G/C promoter gene polymorphism and obesity in a systematic review and meta-analysis study.

Methods: In the present study Science Direct,Medline, Embase, Google Scholar, PubMedand SID search engines have been searched until March 2016. Articles were evaluated using the key words IL6 plus polymorphism or mutation or variant and adiposity, BMI and obesity. Data was analyzed using STATA software (12th version). OR ratio was calculated with 95% confidence interval to evaluate the strength in link between IL6 gene and obesity. Heterogeneity was calculated using I2 test. Articles bias was evaluated using funnel plot versus standard error (SE). The asymmetrydegree of the funnel plot was tested using linear regression tests ofEgger's and Begg's.

Results: Generally, 12 articles entered systematic review and 6 articles entered final meta-analysis. After data was extracted, the total case group consisted of 5343 people and control group consisted of 3449 people. The odds ratio was estimated for additive model CC vs GC (OR= 1; CI: 95%: 0/9-1/12), recessive model CC + GC vs GG (OR= 1/04; CI: 95%: 0/95- 1/15) and for dominant model (OR= 1/10; CI: 95%: 1-1/21). Also the results showed that there is a statistically significant relationship between IL-61-74 G/C gene polymorphism and obesity (P <0/05).

Conclusion: Generally, the results of the present study show that the IL-6 -174 G/C gene polymorphism is related to the obesity.

Keywords


Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/

1. Yanovski SZ, Yanovski JA, Alstair JJ. Drug therapy. N Engl J Med. 2002;346(8):591-602.
https://doi.org/10.1056/NEJMra012586
PMid:11856799
 
2. Barsh GS, Farooqi IS, O'rahilly S. Genetics of body-weight regulation. Nature. 2000;404(6778):644-51.
https://doi.org/10.1038/35007519
PMid:10766251
 
3. Lewis JP, Shuldiner AR. Genetics of the metabolic complications of obesity. Prog Mol Biol Transl Sci. 2009;94:349-72.
https://doi.org/10.1016/B978-0-12-375003-7.00012-1
PMid:21036331
 
4. Hauner H. Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc. 2005;64(2):163-9. [PubMed: 15960861].
https://doi.org/10.1079/PNS2005428
PMid:15960861
 
5. Rostami F, Hosseini R, Sharifi K, Daneshpour M, Azizi F, Hedayati M. Association of G-174C polymorphism of the interleukin-6 gene promoter with obesity in Iranian population. Int J Med Health Sci. 2010;4(9):400-3.
 
6. Qi L, Zhang C, van Dam RM, Hu FB. Interleukin-6 genetic variability and adiposity: associations in two prospective cohorts and systematic review in 26,944 individuals. J Clin Endocrinol Metab. 2007;92(9):3618-25.
https://doi.org/10.1210/jc.2007-0877
PMid:17623760
 
7. Wernstedt I, Eriksson AL, Berndtsson A, Hoffstedt J, Skrtic S, Hedner T, et al. A common polymorphism in the interleukin-6 gene promoter is associated with overweight. Int J Obes Relat Metab Disord. 2004;28(10):1272-9.
https://doi.org/10.1038/sj.ijo.0802763
PMid:15303107
 
8. Sopasakis VR, Sandqvist M, Gustafson B, Hammarstedt A, Schmelz M, Yang X, et al. high local concentrations and effects on differentiation implicate interleukin‐6 as a paracrine regulator. Obes Res. 2004;12(3):454-60.
https://doi.org/10.1038/oby.2004.51
PMid:15044662
 
9. Lieb W, Pavlik R, Erdmann J, Mayer B, Holmer SR, Fischer M, et al. No association of interleukin-6 gene polymorphism (− 174 G/C) with myocardial infarction or traditional cardiovascular risk factors. Int J Cardiol. 2004;97(2):205-12.
https://doi.org/10.1016/j.ijcard.2003.07.038
PMid:15458685
 
10. Moffett SP, Zmuda JM, Cauley JA, Stone KL, Nevitt MC, Ensrud KE, et al. Association of the G‐174C variant in the interleukin‐6 promoter region with bone loss and fracture risk in older women. J Bone Miner Res. 2004;19(10):1612-8.
https://doi.org/10.1359/JBMR.040707
PMid:15355555
 
11. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102(7):1369-76.
https://doi.org/10.1172/JCI2629
PMid:9769329 PMCid:PMC508984
 
12. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000;275(24):18138-44.
https://doi.org/10.1074/jbc.M000379200
PMid:10747905
 
13. Acalovschi D, Wiest T, Hartmann M, Farahmi M, Mansmann U, Auffarth GU, et al. Multiple levels of regulation of the interleukin-6 system in stroke. Stroke. 2003;34(8):1864-9.
https://doi.org/10.1161/01.STR.0000079815.38626.44
PMid:12843357
 
14. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603-5.
https://doi.org/10.1007/s10654-010-9491-z
PMid:20652370
 
15. Hu P, Huang MY, Hu XY, Xie XJ, Xiang MX, Liu XB, et al. Meta- analysis of C242T polymorphism in CYBA genes: risk of acute coronary syndrome is lower in Asians but not in Caucasians. J Zhejiang Univ Sci B. 2015;16(5):370-9.
https://doi.org/10.1631/jzus.B1400241
PMid:25990054 PMCid:PMC4432989
 
16. Xiong J, He Z, Zeng X, Zhang Y, Hu Z. Association of vitamin D receptor gene polymorphisms with systemic lupus erythematosus: a meta-analysis. Clin Exp Rheumatol. 2014; 32(2):174-81. [PubMed: 24321519].
 
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557.
https://doi.org/10.1136/bmj.327.7414.557
PMid:12958120 PMCid:PMC192859
 
18. Gong JY, Sun YH. Association of VEGF gene polymorphisms with diabetic retinopathy: a meta-analysis. PLoS One. 2013; 8(12):e84069. doi: 10.1371/journal.pone.0084069. [PubMed: 24376787].
https://doi.org/10.1371/journal.pone.0084069
PMid:24376787 PMCid:PMC3869859
 
19. Berthier MT, Paradis AM, Tchernof A, Bergeron J, Prud'homme D, Després JP, et al. The interleukin 6-174G/C polymorphism is associated with indices of obesity in men. J Hum Genet. 2003;48(1):14-9.
https://doi.org/10.1007/s100380300002
PMid:12560873
 
20. Stephens JW, Hurel SJ, Cooper JA, Acharya J, Miller GJ, Humphries SE. A common functional variant in the interleukin-6 gene is associated with increased body mass index in subjects with type 2 diabetes mellitus. Mol Genet Metab. 2004;82(2):180-6.
https://doi.org/10.1016/j.ymgme.2004.04.001
PMid:15172007
 
21. Marti A, Martinez-González MA, Martinez JA. Interaction between genes and lifestyle factors on obesity. Proc Nutr Soc. 2008;67(1):1-8.
https://doi.org/10.1017/S002966510800596X
PMid:18234126
 
22. Bennermo M, Held C, Stemme S, Ericsson CG, Silveira A, Green F, et al. Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases? Clin Chem. 2004;50(11):2136-40.
https://doi.org/10.1373/clinchem.2004.037531
PMid:15364891
 
23. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000;148(2):209-14.
https://doi.org/10.1016/S0021-9150(99)00463-3
PMid:10657556
 
24. Björntorp P. Body fat distribution, insulin resistance, and metabolic diseases. Nutrition. 1997;13(9):795-803. [PubMed: 9290093].
https://doi.org/10.1016/S0899-9007(97)00191-3
PMid:9290093
 
25. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395(6704):763-70.
https://doi.org/10.1038/27376
PMid:9796811
 
26. Cimponeriu D, Serafinceanu C, Apostol P, Toma M, Stavarachi M, Radu I, et al. Potential association of obesity with IL6 G- 174C polymorphism and TTV infections. Central Eur J Biol. 2013;8(7):625-32.
https://doi.org/10.2478/s11535-013-0178-1
 
27. Hamid Y, Rose C, Urhammer S, Glümer C, Nolsøe R, Kristiansen O, et al. Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia. 2005;48(2):251-60.
https://doi.org/10.1007/s00125-004-1623-0
PMid:15645209
 
28. Poitou C, Lacorte JM, Coupaye M, Bertrais S, Bedel JF, Lafon N, et al. Relationship between single nucleotide polymorphisms in leptin, IL6 and adiponectin genes and their circulating product in morbidly obese subjects before and after gastric banding surgery. Obes Surg. 2005;15(1):11-23.
https://doi.org/10.1381/0960892052993431
PMid:15760495
 
29. Huth C, Illig T, Herder C, Gieger C, Grallert H, Vollmert C, et al. Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant-174G> C with circulating glucose levels, interleukin-6 levels, and body mass index. Ann Med. 2009;41(2):128-38.
https://doi.org/10.1080/07853890802337037
PMid:18752089 PMCid:PMC3801210
 
30. Yu Z, Han S, Cao X, Zhu C, Wang X, Guo X. Genetic polymorphisms in adipokine genes and the risk of obesity: a systematic review and meta‐analysis. Obesity. 2012;20(2):396- 406.
https://doi.org/10.1038/oby.2011.148
PMid:21660081
 
31. Klipstein‐Grobusch K, Möhlig M, Spranger J, Hoffmann K, Rodrigues FU, Sharma AM, et al. Interleukin‐6 g.− 174G> C promoter polymorphism is associated with obesity in the EPIC‐potsdam study. Obesity. 2006;14(1):14-8.
https://doi.org/10.1038/oby.2006.3
PMid:16493118
 
32. Bouhaha R, Baroudi T, Ennafaa H, Vaillant E, Abid H, Sassi R, et al. Study of TNFα-308G/A and IL6-174G/C polymorphisms in type 2 diabetes and obesity risk in the Tunisian population. Clin Biochem. 2010;43(6):549-52.
https://doi.org/10.1016/j.clinbiochem.2010.01.008
PMid:20132806
 
33. Underwood PC, Chamarthi B, Williams JS, Sun B, Vaidya A, Raby BA, et al. Replication and meta-analysis of the gene- environment interaction between body mass index and the interleukin-6 promoter polymorphism with higher insulin resistance. Metabolism. 2012;61(5):667-71.
https://doi.org/10.1016/j.metabol.2011.09.018
PMid:22075267 PMCid:PMC3461261